Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top
Current Cardiology Reports

Cardiovascular Risk Associated with the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults

Published in:
Authors
Aditi Kothari
John Paul Aparece
Raul del Toro Mijares
Published in
Current Cardiology Reports | Issue 1/2025

Abstract

Purpose of review

The increasing prevalence of attention deficit hyperactivity disorder (ADHD) makes it important to study the cardiovascular implications of this disease and the drugs used to treat it. As more patients are diagnosed with ADHD across the world and these medications are prescribed more, it is imperative to understand the cardiovascular risk profile associated with these medications. This narrative review will highlight the importance of considering cardiovascular risk factors inherent to ADHD and the medications currently used to treat it.

Recent findings

Chronic sympathetic activation as caused by ADHD therapies has numerous effects on the cardiovascular system including an increase in blood pressure and heart rate. These changes could potentially lead to heart failure, arrythmias or even sudden cardiac death.

Summary

While a few studies that have shown no correlation between ADHD medications and cardiovascular effects, current guidelines recommend a thorough assessment prior to initiating treatment and periodic monitoring during treatment.
Title
Cardiovascular Risk Associated with the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
Authors
Aditi Kothari
John Paul Aparece
Raul del Toro Mijares
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 1/2025
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-025-02223-w
This content is only visible if you are logged in and have the appropriate permissions.

Other articles of this Issue 1/2025

Beyond the Heart: Exploring Extracardiac Manifestations in Cardiac Amyloidosis for Early Diagnosis

  • Amyloidosis
  • Cardiac PET, CT, and MRI (P Cremer, Section Editor)

Transthyretin Cardiac Amyloidosis: Current and Emerging Therapies

  • Open Access
  • Amyloidosis
  • Myocardial Disease (A Abbate and M Merlo, Section Editors)

Cardiac Magnetic Resonance Guidance for the Pathogenetic Definition of Cardiomyopathies

  • Open Access
  • Cardiac MRI
  • Myocardial Disease (A Abbate and M Merlo, Section Editors)

Artificial Intelligence Applications in Cardio-Oncology: A Comprehensive Review

Use of Acetazolamide in People with Decompensated Heart Failure: A Systematic Review and Meta-Analysis

Equity by Design – Using Digital Technology To Overcome Cardiovascular Health Disparities

  • Open Access
  • Digital Health
  • Diversity and Health Equity in Cardiology (AE Johnson, Section Editor)

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME